Albert Yuzpe

No ORCID on file · 3 papers in corpus
rct 2005
A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon) in women undergoing controlled ovarian hyperstimulation for IVF treatment
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-005-1497-1

PURPOSE: To compare the efficiency and efficacy of two starting doses of recombinant FSH (follitropin-beta, Puregon) in women undergoing IVF treatment. METHODS: This prospective, randomized, double-blind, multicentric (N = 6) study include…

nonrandomized-trial 1997
Therapeutic efficacy and bone mineral density response during and following a three-month re-treatment of endometriosis with nafarelin (Synarel)
American journal of obstetrics and gynecology ·doi:10.1016/s0002-9378(97)70084-x

OBJECTIVE: Our goal was to determine the effects of a repeated course of the gonadotropin-releasing hormone agonist nafarelin on symptoms and signs of endometriosis and lumbar and distal radius bone mineral density. STUDY DESIGN: Forty-fiv…

observational 1995
Cumulative pregnancy rates and pregnancy outcome after in-vitro fertilization: > 5000 cycles at one centre
Human Reproduction ·doi:10.1093/oxfordjournals.humrep.a135964

Cumulative pregnancy rates and pregnancy outcome analysis are useful methods for advising an infertile couple of the probability of in-vitro fertilization (IVF) success. All 5209 IVF cycles in 2391 couples at University Hospital, London, On…